| |
Article Title |
Author(s) |
Pages |
|
|
|
Masthead
|
|
IFC
|
|
|
|
Listing of Plenary, Oral and Poster Presentations of the 32nd Annual Meeting of the American Brachytherapy Society
PL01 Presentation Time: 11:00 AM
|
|
S1-S13
|
|
|
|
Accelerated Partial Breast Irradiation With Interstitial Brachytherapy for Women With Breast Cancer in the Presence of Breast Augmentation
Purpose: The number of women undergoing augmentation mammoplasty has increased 894% over the past 14 years. More women are being diagnosed with breast cancer in the presence of implants. By their natu...
|
Rezwan Chowdhury,
Coral A. Quiet,
Mustafa Ozer,
Salih Gurdalli,
Robert R. Kuske
et al.
|
S14
|
|
|
|
Pre-Implant Clinical and Radiological MRI Assessment Improves CT-Based HRCTV Delineation in Cervical Cancer Patients
Purpose: In the past decade the approach to brachytherapy boost for cervical cancer patients evolved from 2D-based planning to a sophisticated 4D image guided adaptation (IGBT), with improvement of LC...
|
Mario Federico,
Neamat Kholosy,
Nicole Nesvacil,
Daniel Berger,
Alina Sturdza,
Christian Kirisits,
Richard Pötter
et al.
|
S14-S15
|
|
|
|
Long-Term Outcome for Very High Risk Prostate Cancer Treated With Permanent Interstitial Brachytherapy
Purpose: The management of high risk prostate cancer remains controversial. Despite cure rates of approximately 40% for high risk patients in the modern radical prostatectomy era, radical prostatectom...
|
Nathan Bittner,
Gregory S. Merrick,
Wayne M. Butler,
Robert W. Galbreath,
Jonathan Leif,
Zachariah A. Allen,
Edward Adamovich,
Kent E. Wallner
et al.
|
S15
|
|
|
|
Dosimetric Feasibility of Prostate Permanent-Seed Implant Brachytherapy Plans Using Non-Parallel Penile-Bulb-Avoiding Needle Geometries
Purpose: Physical damage to the cavernous arteries running along the side of the penile bulb has been shown to cause erectile dysfunction. It is reasonable to hypothesize that trauma from needle punct...
|
J. Adam M. Cunha,
Vasant Kearney,
Vivian K. Weinberg,
Jean Pouliot
|
S15-S16
|
|
|
|
20 Gy vs 44 Gy of Supplemental External Beam Radiation With 103Pd Brachytherapy for Patients With Higher Risk Disease: Results of a Prospective Randomized Trial
Purpose: The necessity of external beam radiation therapy (XRT) as a supplement to prostate brachytherapy remains unknown. Herein we report prostate brachytherapy biochemical control rates for patient...
|
Al V. Taira,
Gregory S. Merrick,
Kent E. Wallner,
Wayne M. Butler,
Robert W. Galbreath,
Zachariah A. Allen,
Edward Adamovich
et al.
|
S16
|
|
|
|
Long-Term Outcomes, Quality of Life, and Patient-Reported Satisfaction Following Prostate Brachytherapy: The M.D. Anderson Cancer Center Experience
Purpose: Men diagnosed with prostate cancer face a myriad of treatment options. In order to help clarify the clinical effectiveness between treatment options, the M.D. Anderson institutional outcomes ...
|
Steven J. Frank,
Mark F. Munsell,
Thomas J. Pugh,
Rajat J. Kudchadker,
Teresa L. Bruno,
Deborah A. Kuban,
Andrew K. Lee,
Seungtaek Choi,
Quynh Nhu Nguyen,
David A. Swanson
et al.
|
S16-S17
|
|
|
|
Interstitial High-Dose-Rate Brachytherapy as Monotherapy for Early Stage Prostate Cancer: Median 8-Year Results in 317 Patients
Purpose: Transrectal ultrasound (TRUS)-guided interstitial implant for prostate cancer using low-dose-rate (LDR) and high-dose-rate (HDR) technique has been reported with results comparing favorably t...
|
Rufus J. Mark,
Paul J. Anderson,
Robin S. Akins,
Murali Nair
|
S17
|
|
|
|
Erectile Function Following 125I Permanent Prostate Brachytherapy: 5- and 8-Year Results in 1411 Men
Purpose: To evaluate the long-term erectile function in men treated with 125I permanent prostate brachytherapy and to determine predictive factors for erectile dysfunction (ED).
|
Amy J. Hayden,
Mira Keyes,
Michael McKenzie,
Tom Pickles,
David Petrik,
Ingrid Spadinger,
Vincent LaPointe,
William J. Morris
et al.
|
S17
|
|
|
|
Acute Toxicity Profiles Associated With Three Distinct High-Dose-Rate Interstitial Brachytherapy Monotherapy Fractionation Schedules
Purpose: To compare the acute toxicity profiles associated with three distinct high-dose-rate interstitial brachytherapy monotherapy (HDR) fractionation schedules: 38 Gy in four fractions (38/4), 24 G...
|
Joshua T. Dilworth,
Michel I. Ghilezan,
Michelle Wallace,
Christina K. Mitchell,
Hong Ye,
Gary S. Gustafson,
Peter Y. Chen,
Daniel J. Krauss,
Alvaro A. Martinez
et al.
|
S17-S18
|
|
|
|
Interstitial High-Dose-Rate Brachytherapy + Intensity Modulated Radiation Therapy vs. High-Dose-Rate Monotherapy for Early Stage Prostate Cancer: Long-Term Followup in 426 Patients
Purpose: Transrectal ultrasound (TRUS)-guided interstitial implant for prostate cancer using High-dose-rate (HDR) + external beam radiation therapy (EBRT) technique has been reported with results comp...
|
Rufus J. Mark,
Paul J. Anderson,
Robin S. Akins,
Murali Nair
|
S18
|
|
|
|
Distant Metastases Following Permenanet Interstitial Brachytherapy for Patients With Clinically Localized Prostate Cancer
Purpose: Recent publications have suggested high risk patients undergoing radical prostatectomy have a lower risk of distant metastases and improved cause-specific survival than patients receiving def...
|
Gregory S. Merrick,
Robert W. Galbreath,
Wayne M. Butler,
Jonathan Lief,
Zachariah A. Allen,
Edward Adamovich,
Kent E. Wallner
et al.
|
S18-S19
|
|
|
|
Prostate Seed Implantation Alone or With External Beam Radiation Reduces Cause-Specific Mortality Compared to External Beam Radiation Alone for Definitive Treatment of Localized Intermediate- to High-Risk Prostate Cancer: A Population Based Analysis
Purpose: The use of prostate seed implantation (PSI) in patients with intermediate and high-risk prostate cancer has been limited by historical concerns regarding inferior outcomes. However, contempor...
|
Xinglei Shen,
Scott W. Keith,
Mark V. Mishra,
Adam P. Dicker,
Timothy N. Showalter
et al.
|
S19
|
|
|
|
Salvage High-Dose-Rate Brachytherapy for Recurrent Prostate Cancer After Ultra High Intensity Modulated Radiotherapy: Results of a Prospective Study
Purpose: The aim of this study was to evaluate the outcomes and late toxicity of salvage high-dose-rate (HDR) brachytherapy for recurrent prostate cancer (PC) after previous ultra high doses of extern...
|
Lisa K. Morikawa,
Michael J. Zelefsky,
Gil’ad N. Cohen,
Marco Zaider,
Sherri M. Donat,
Yoshiya Yamada
et al.
|
S19
|
|
|
|
Adaptive MR/CT Image-Guided Brachytherapy for Cervical Cancer Patients, With MRI Only at First Fraction
Purpose: At the Medical University of Vienna the standard for HDR brachytherapy (BT) for cervix cancer patients is to apply four fractions (7 Gy each) in two applications which are done in consecutive...
|
Nicole Nesvacil,
Anna Lettmayer,
Mario Federico,
Alina Sturdza,
Neamat Kholosy,
Daniel Berger,
Petra Trnkova,
Richard Pötter,
Christian Kirisits
et al.
|
S19-S20
|
|
|
|
Withdrawn
|
|
S20
|
|
|
|
D2cc Rectum and Tumor Volume Predict for GI Toxicity in HDR Interstitial Brachytherapy for Gynecologic Cancer
Purpose: To evaluate high-dose-rate (HDR) interstitial brachytherapy for gynecologic cancer and report the rates of grade 3 or higher complications, local control and survival.
|
Larissa Lee,
Akila Viswanathan
|
S20
|
|
|
|
Dosimetric Impact of Interfraction Tandem-Ring Applicator and Catheter Movement in High-Dose-Rate Brachytherapy for Gynecology Patients
Purpose: Prior studies have reported the interfraction motion of the ring-tandem applicator, but the resulting dosimetric impact has not been quantified. The goal of our study was to determine the dos...
|
Dilini Pinnaduwage,
J. Adam Cunha,
Devan Krishnamurthy,
Marc Nash,
I-Chow Hsu,
Jean Pouliot
et al.
|
S20-S21
|
|
|
|
3D Image-Based HDR Interstitial Brachytherapy for Vaginal Cancer
Purpose: To evaluate dosimetric results and clinical outcomes of 3D image-based HDR interstitial brachytherapy for vaginal cancer.
|
Jean-Claude M. Rwigema,
Sushil Beriwal,
Emma Higgins,
Hayeon Kim,
Paniti Sukumvanich,
Alexander Olawaiye,
Scott Richard,
Joseph L. Kelley,
Robert P. Edwards,
Thomas C. Krivak
et al.
|
S21
|
|
|
|
Dosimetric Analysis of Small Bowel Doses Received During MRI-Based 3D Brachytherapy for Cervical Cancer
Purpose: To assess doses received by the small bowel during MRI-based 3D brachytherapy for cervical cancer, following the Gynecologic GEC ESTRO recommendations. To evaluate the high risk CTV (HR-CTV) ...
|
Victoria Beenstock,
Vinod Mullassery,
Gerry Lowe,
Linda Bryant,
Caroline Chapman,
Peter Hoskin
et al.
|
S21-S22
|
|
|
|
Assessment of Bladder Dose Location in MRI Guided Adaptive Cervical Cancer Brachytherapy
Purpose: To assess the location of the most exposed volume of bladder in cervical cancer patients treated with EBRT plus fractionated BT and to define classes for morbidity correlation.
|
Daniel Berger,
Margit Valgma,
Petra Georg,
Elena Fidarova,
Wolfgang Dorr,
Johannes A.C. Dimopoulos,
Christian Kirisits,
Richard Pötter
et al.
|
S22
|
|
|
|
Evaluation of a Balloon-Based Vaginal Packing System and Minimal Sedation for Patients With Cervical Cancer Undergoing Intracavitary Brachytherapy
Purpose: This retrospective study reviews a methodological shift in intracavitary brachytherapy (ICBT) treatment at the University of Pennsylvania from: 1) the traditional vaginal packing to the emplo...
|
Meng X. Welliver,
Lilie Lin
|
S22-S23
|
|
|
|
Image and Laparoscopic Guided Interstitial Pulsed-Dose-Rate Brachytherapy for Locally Advanced Primary or Recurrent Gynecologic Cancer Using a 4D Target Concept
Purpose: To assess treatment outcome of image and laparoscopic guided interstitial interstitial pulsed-dose-rate brachytherapy (PDR-BT) for locally advanced primary or recurrent gynecologic cancer usi...
|
Lars Fokdal,
Soren Kynde Nielsen,
Kari Tanderup,
Henrik Kidmose Christensen,
Jacob Lindegaard
et al.
|
S23
|
|
|
|
Intraoperative 125I Brachytherapy Mesh After Sublobar Resection in Early Stage High Risk Non Small Cell Lung Cancer
Purpose: To assess the outcome and local recurrence rate of early stage non-small cell lung cancer (NSCLC) patients with poor cardiopulmonary status treated with Vicryl mesh brachytherapy following su...
|
Mohsen Isaac,
Anna Kaminsky,
Victor G. Onufrey,
Jason Lamb,
Judith Figura
et al.
|
S23-S24
|
|
|
|
Episcleral Plaque Brachytherapy for Uveal Melanomas: 20 Years’ Institutional Experience
Purpose: To present the results of patients with uveal melanomas treated at The Ohio State University Comprehensive Cancer Center.
|
Mersiha Hadziahmetovic,
Christopher Pelloski,
Subir Nag,
Douglas D. Martin
|
S24
|
|
|
|
Preliminary Clinical Results Using Valencia Applicator and a New Fractionation in Non Melanoma Skin Cancer Treatments
Purpose: Non-melanoma skin cancers have been treated with different modalities: surgery alone or in combination with external beam radiotherapy or interstitial low-dose-rate brachytherapy. Recently, t...
|
Alejandro Tormo,
Jose Perez-Calatayud,
Susana Roldan,
Francoise Lliso,
Sandra Miranda,
Vicente Carmona,
Paola Antonini,
Michael Kasper,
Zoubir Ouhib,
Conrad Pujol,
Antonio Ballesta
et al.
|
S24
|
|
|
|
Intravascular Brachytherapy for Coronary In-Stent Restenosis: Medical University of South Carolina's Single Institution Long-Term Experience
Purpose: Intracoronary brachytherapy (ICB) remains the only FDA approved treatment modality for bare metal stent (BMS) in-stent restenosis (ISR); however, ICB has been largely abandoned due to logisti...
|
Isaac F. Dingle,
Amy E. Wahlquist,
Kenneth N. Vanek,
Anand K. Sharma,
Christopher D. Nielsen,
Jennifer L. Harper
et al.
|
S24-S25
|
|
|
|
Permanent Implantation of 125I Seeds as a Salvage Therapy for Head and Neck Carcinoma After Radiotherapy
Purpose: The management of recurrent head and neck cancer pose a challenging problem. To assess the feasibility, efficacy, and morbidity of 125I seed implantation for recurrent head and neck carcinoma...
|
Jinna Li,
Ang Qu,
Yuliang Jiang,
Junjie Wang,
Weiqiang Ran,
Huishu Yuan,
Na Meng,
Ping Jiang,
Ruijie Yang
et al.
|
S25
|
|
|
|
Preoperative Concomittant Chemotherapy/EBRT With HDR Brachytherapy Boost for Rectal Adenocarcinoma: The Initial Moffitt Cancer Center Experience
Purpose: Preoperative concomitant chemoradiotherapy is the standard of care for ≥T3 or node positive disease rectal cancer. Additionally, high-dose-rate (HDR) endorectal brachytherapy can effectively ...
|
Michael D. Chuong,
Sarah E. Hoffe,
Ravi Shridhar,
Matthew C. Biagioli
|
S25-S26
|
|
|
|
Preoperative HDR Brachytherapy for Rectal Adenocarcinoma in Previously Irradiated Patients: The Initial Moffitt Cancer Center Experience
Purpose: High-dose-rate (HDR) preoperative endorectal brachytherapy can effectively downstage rectal cancers, resulting in both increased local control and sphincter preservation for lower one-third t...
|
Michael D. Chuong,
Sarah E. Hoffe,
Ravi Shridhar,
Matthew C. Biagioli
|
S26
|
|
|
|
Online Treatment Planning for Transrectal Ultrasound Guided Interstitial HDR Brachytherapy (IABT) Boost With Complementary External Beam Irradiation in Anal Cancer
Purpose: Primary radiotherapy in form of external beam radiotherapy (EBRT) combined with chemotherapy or combined with local dose escalation by brachytherapy enables anal sphincter preservation and ca...
|
Peter Niehoff,
Frank-Andre Siebert,
Bodo Schniewind,
Volker Kahlke,
Marek Doniec,
Gyorgy Kovacs
et al.
|
S26
|
|
|
|
Customized Intraoperative 32P High-Dose-Rate Brachytherapy of the Dura
Purpose: Brachytherapy is the ideal vehicle to deliver tumorcidal doses of radiation to the dura while minimizing dose to the spinal cord or other nearby dose sensitive structures. The dural margin is...
|
Yoshiya Yamada,
Gil’ad Cohen,
Marco Zaider,
Thomas Golembeski,
Lawrence Dauer,
Mark Bilsky
et al.
|
S26-S27
|
|
|
|
Can Intraoperative US-Based Planning Effectively Replace Postoperative CT-Based Planning for HDR Prostate Brachytherapy?
Purpose: Growing evidence demonstrates that boosting prostate dose using HDR brachytherapy (BT) confers a survival advantage for intermediate-risk prostate patients. Intraoperative US-based planning a...
|
Deidre L. Batchelar,
Sam Blake,
D. Andrew Loblaw,
Hans Chung,
Niki Law,
Thomas Cisecki,
Gerard C. Morton
et al.
|
S27
|
|
|
|
Five-Year Biochemical Control Following Cesium-131 Permanent Prostate Brachytherapy in a Multi-institutional Trial
Purpose: Cs-131 was introduced as an alternative, shorter half-life istope to 125I and 103Pd for prostate LDR brachytherapy in 2004. This 100-patient, multi-institutional trial was opened in that year...
|
Bradley Prestidge,
William Bice,
Brian Moran,
Donald Fuller,
James Gray,
David Beyer,
Steven Kurtzman,
John Sylvester,
Louis Potters
et al.
|
S27-S28
|
|
|
|
Definition and Dosimetric Evaluation of a Clinical Target Volume (CTV) in the Post Implant (CT/MR Fusion) Analysis of Low-Dose-Rate Brachytherapy for Prostate Cancer at Princess Margaret Hospital
Purpose: The extent of extra prostatic extension in low and intermediate risk prostate cancer is mostly confined within a radial distance of 3mm which have implications in evaluating the post-implant ...
|
Elantholi P. Saibishkumar,
Douglas Iupati,
Jette Borg,
Kimberly A. Fernandes
|
S28
|
|
|
|
Dose-Escalated Adaptive Image-Guided Radiotherapy Versus Pelvic Irradiation With High-Dose-Rate Brachytherapy Boost for High-Risk Prostate Cancer
Purpose: Compare clinical outcomes in high-risk prostate cancer patients treated with either dose-escalated adaptive image-guided radiotherapy (IGRT) or pelvic external beam radiation therapy with hig...
|
Larry L. Kestin,
Ovidiu Marina,
Michel I. Ghilezan,
Chirag Shah,
Gary Gustafson,
Donald S. Brabbins,
Hong Ye,
Michelle Wallace,
Daniel J. Krauss,
Frank A. Vicini,
Alvaro A. Martinez
et al.
|
S28-S29
|
|
|
|
Comparison Between Pre-Planning and Real-Time Planning Techniques in 125I Prostate Brachytherapy by Postimplant Dosimetry, Toxicity and Five-Year Biochemical Outcomes in 665 Patients
Purpose: To compare two widely used seed implant techniques: pre-planning and intraoperative real-time planning; based on postplan dosimetry, toxicity and biochemical outcomes.
|
Atsunori Yorozu,
Kazuhito Toya,
Yutaka Shiraishi,
Kayo Yoshida,
Tomoya Kaneda,
Toru Nishiyama,
Shiro Saito,
Toshio Ohashi
et al.
|
S29
|
|
|
|
Should We Deliver High Dose-Rate Brachytherapy Boost for Prostate Cancer as a Single Fraction?
Purpose: High-dose-rate (HDR) brachytherapy for prostate cancer is most commonly given in multiple fractions combined with external beam radiotherapy (EBRT) over 4 to 5 weeks. The purpose of this repo...
|
Gerard C. Morton,
D. Andrew Loblaw,
Hans T. Chung,
Niki Law,
Thomas Cisecki,
Batchelar Deidre,
Renee Korol,
Andrea Deabreu,
Raxa Sankreacha
et al.
|
S29-S30
|
|
|
|
Prostate MRI in Men With Intermediate-Risk Prostate Cancer: Implications for Prostate Brachytherapy Monotherapy
Purpose: To determine the test performance of prostate MRI (P-MRI) in the context of making medical decisions for prostate brachytherapy monotherapy in men with intermediate risk prostate cancer.
|
Thomas J. Pugh,
Steven J. Frank,
Rajat Kudchadker,
David A. Swanson,
John W. Davis
et al.
|
S30
|
|
|
|
Dose-Escalated Adaptive Image-Guided Radiotherapy Versus Pelvic Irradiation With High-Dose-Rate Brachytherapy Boost for Intermediate-Risk Prostate Cancer
Purpose: Compare clinical outcomes in intermediate-risk prostate cancer patients treated with either dose-escalated adaptive image-guided radiotherapy (IGRT) or pelvic external beam radiation therapy ...
|
Ovidiu Marina,
Larry L. Kestin,
Michel I. Ghilezan,
Chirag Shah,
Gary Gustafson,
Donald S. Brabbins,
Hong Ye,
Michelle Wallace,
Daniel J. Krauss,
Frank A. Vicini,
Alvaro A. Martinez
et al.
|
S30-S31
|
|
|
|
Transperineal Template-Guided Mapping Biopsy as a Staging Procedure to Select Patients Best Suited for Active Surveillance: Implications for Treatment Planning
Purpose: Patients with clinically insignificant prostate cancer using the Epstein criteria diagnosed by transrectal ultrasound-guided needle biopsy (TRUS) are considered outstanding candidates for act...
|
Gregory S. Merrick,
Wayne M. Butler,
Robert W. Galbreath,
Jonathan Lief,
Zachariah A. Allen,
Richard Anderson,
Edward Adamovich,
Kent E. Wallner,
Nathan Bittner
et al.
|
S31
|
|
|
|
A Dosimetric Uncertainty Analysis for Photon-Emitting Brachytherapy Sources: Report of AAPM Task Group No. 138 and GEC-ESTRO
Purpose: This report addresses uncertainties pertaining to brachytherapy single-source dosimetry preceding clinical use. NIST Technical Note 1297 is standard for uncertainty formalism. Uncertainties i...
|
Larry A. DeWerd,
Geoffrey S. Ibbott,
Ali S. Meigooni,
Michael G. Mitch,
Mark J. Rivard,
Kurt E. Stump,
Bruce R. Thomadsen,
Jack L.M. Venselaar
et al.
|
S31-S32
|
|
|
|
Different Tissue Modeling Schemes in Post-implant Assessment of Breast LDR Brachytherapy
Purpose: Breast is a highly heterogeneous organ which is mostly a mixture of glandular and adipose tissues. The proportion of glandular/adipose tissue varies widely between patients and depends on dif...
|
Hossein Afsharpour Afsharpour,
Guillaume Landry,
Brigitte Reniers,
Jean-Philippe Pignol,
Luc Beaulieu,
Frank Verhaegen
et al.
|
S32
|
|
|
|
Dosimetric Uncertainties in the Practice of Clinical Brachytherapy
Purpose: A systematic overview of dosimetric uncertainties was performed. This included a means of identifying, classifying, quantifying, and properly combining these individual uncertainties towards ...
|
Christian Kirisits,
Mark Rivard,
Facundo Ballester,
Dimos Baltas,
Marisol de Brabandere,
Taran Paulsen Hellebust,
Rob van der Laarse,
Tibor Major,
Yury Niatsetski,
Panos Papagiannis,
Jose Perez-Calatayud,
Alex Rijnders,
Kari Tanderup,
Frank-Andre Siebert
et al.
|
S32-S33
|
|
|
|
Modeling a Hypothetical 57Co Source for Brachytherapy Application
Purpose: To investigate 57Co as a possible candidate for brachytherapy. The characteristic of the radionuclide 57Co is highly interesting for its use as a brachytherapy source. 57Co combines a possibl...
|
Shirin A. Enger,
Luc Beaulieu
|
S33
|
|
|
|
Dynamic Modulated Brachytherapy (DMBT): Concept, Design, and System Development
Purpose: To develop a prototype, robotic delivery system for intracavitary, high-dose-rate (HDR) brachytherapy which enables dynamic intensity modulation. The proposed system optimizes the target volu...
|
Matthew J. Webster,
Danial J. Scanderbeg,
W. Tyler Watkins,
Jonathan Stenstrom,
Joshua D. Lawson,
William Y. Song
et al.
|
S33-S34
|
|
|
|
Dosimetry Comparison Between TG-43 and Monte Carlo Calculations Using the Freiburg Flap for Skin HDR Brachytherapy
Purpose: Freiburg Flap is a flexible mesh surface mold with channels of flexible implants tubes 1 cm apart. This device is used in HDR for skin treatment. It consists of a large sheet of connected pla...
|
Javier Vijande,
Maria del Carmen Pujades-Claumarchirant,
Domingo Granero,
Zoubir Ouhib,
Facundo Ballester,
Jose Perez-Calatayud
et al.
|
S34
|
|
|
|
Using Deformable Image Registration to Obtain Composite 3D Dose for External Beam and Brachytherapy of Cervical Cancer Treatment
Purpose: Radiation treatments of cervical cancer normally include both external beam radiation therapy (EBRT) and intracavitary brachytherapy (ICBT). One of the greatest challenges in assessing delive...
|
Zhiqian H. Yu,
Ann H. Klopp,
Yongbin Zhang,
Patricia Eifel,
Lei Dong,
Firas Mourtada
et al.
|
S34-S35
|
|
|
|
Dosimetric Characterization of Surface Applicators Used With the Axxent® Electronic Brachytherapy System
Purpose: This investigation was performed to determine if the American Association of Physicists in Medicine TG-61 protocol for x-ray dosimetry is appropriate and how it may need to be modified for us...
|
Regina M. Kennedy,
Tina L. Pike,
John A. Micka,
Larry A. DeWerd
|
S35
|
|
|
|
Monte Carlo Verification of a CT/MR Ovoid Model Used by a Grid-Based Boltzmann Solver in a Commercial Treatment Planning System
Purpose: A commercial TPS is available that accounts for patient boundaries, applicator materials, and tissue heterogeneities. A library of HDR brachytherapy applicators is included with the TPS. The ...
|
Justin Mikell,
Firas Mourtada
|
S36
|
|
|
|
Multi-lumen Breast Brachytherapy in Patients With 5 mm or Less Balloon Surface-Skin Distance (BSD) Using the Contura™ Brachytherapy Catheter
Purpose: To evaluate the toxicity of multi-lumen breast brachytherapy in patients with 5 mm or less balloon surface-skin distance (BSD) treated with the Contura™ catheter.
|
Daniel Reed,
Chris Biggs,
Terry Lee,
Kevin Rogers,
Frank Rafie
et al.
|
S36
|
|
|
|
Interstitial High-Dose-Rate Brachytherapy for Early Stage Breast Cancer: Median 6-Year Followup of 273 Cases Using Multi-catheter Technique
Purpose: External Beam Radiation Therapy (EBRT) has been the standard of care for breast conservation radiation therapy. Recent data indicate that interstitial implant and High-dose-rate (HDR) radiati...
|
Rufus J. Mark,
Paul J. Anderson,
Robin S. Akins,
Murali Nair
|
S36-S37
|
|
|
|
A Multi-institutional Study of Implementation, Tolerance and Early Clinial Results With Non-invasive Image-Guided Breast Brachytherapy for Tumor Bed Boost
Purpose: Noninvasive image-guided breast brachytherapy (NIIGBB) is a mammography-based, brachytherapy system (Accuboost®) whereby the treatment applicators are centered on the planning target volume (...
|
Subarna Hamid,
Douglas Arthur,
Sandra J. Sha,
Sean Cavanaugh,
Rashmi Benda,
Bradley Prestidge,
Scot Ackerman,
Robert Kuske,
Coral Quiet,
David E. Wazer
et al.
|
S37
|
|
|
|
Factors Associated With Optimal Cosmetic Results at 60 Months in Patients Treated With Accelerated Partial Breast Irradiation on the American Society of Breast Surgeons MammoSite Breast Brachytherapy Registry Trial
Purpose: To evaluate factors associated with optimal cosmetic results at 60 months for early-stage breast cancer patients enrolled on the American Society of Breast Surgeons (ASBrS) MammoSite Breast B...
|
Martin Keisch,
Frank Vicini,
Peter Beitsch,
Sharad Goyal,
Atif Khan,
Maureen Lyden,
Bruce Haffty
et al.
|
S37-S38
|
|
|
|
Clinical Outcomes in Patients Treated With Accelerated Partial Breast Irradiation Versus Whole-Breast Irradiation: Results of Two Matched Pair Analyses
Purpose: To compare clinical outcomes in patients receiving adjuvant radiation therapy limited to the tumor bed (APBI) with patients receiving traditional whole-breast irradiation (WBI).
|
Chirag Shah,
J. Vito Antonucci,
Michelle Wallace,
Christina Mitchell,
Pamela Benitez,
Nayana Dekhne,
Hong Ye,
Peter Chen,
Alvaro A. Martinez,
Frank A. Vicini
et al.
|
S38
|
|
|
|
Pacemaker Dose in High-Dose-Rate Balloon Brachytherapy for Breast Cancer Treatment
Purpose: As life expectancy has been increased due to better medical management and artificial cardiac pacemakers have become more common, more patients with these devices in-situ are presenting with ...
|
Yongbok Kim,
Youssef Arshoun,
Mark G. Trombetta
|
S38-S39
|
|
|
|
Comparison of Target Breast Volume Treated for Accelerated Partial Breast Irradiation Devices
Purpose: The Strut Adjusted Volume Implant, SAVI, is a multi-catheter, single entry brachytherapy device for accelerated partial breast irradiation (APBI) designed for adaptability to anatomic constra...
|
Catheryn Yashar,
Miriam Graf,
Kishore Dass,
Jondavid Pollock,
Ernest Butler,
Robert Hong,
Huaying Ji,
Virginia Lorio,
Don McRae,
Coral Quiet,
Robert Kuske,
Daniel Scanderbeg
et al.
|
S39
|
|
|
|
Pathologic Features Associated With Locoregional Recurrence Following Brachytherapy-Based Accelerated Partial Breast Irradiation
Purpose: We began treating patients with brachytherapy-based accelerated partial breast irradiation (APBI) at our institution in 2000. The purpose of the current analysis is to report the mature disea...
|
Derek R. McHaffie,
Rakesh R. Patel,
Rupak K. Das,
Heather M. Geye,
George M. Cannon
et al.
|
S39-S40
|
|
|
|
Patterns of Care Analysis for Patients Undergoing Breast Brachytherapy: A SEER Study
Purpose: The 2002 FDA approval of the MammoSite catheter, the first of several modern breast brachytherapy devices led to a surge of interest in breast brachytherapy. Until very recently, guidelines a...
|
Zain A. Husain,
Usama Mahmood,
Steven J. Feigenberg
|
S40
|
|
